{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:50:49Z","timestamp":1793296249928,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bronchiectasis is a highly heterogeneous chronic airway disease with marked geographic and ethnic variations. Most influential cohort studies to date have been performed in Europe and USA, which serve as the examples for developing a cohort study in China where there is a high burden of bronchiectasis. The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China) is designed to: (1) describe the clinical characteristics and natural history of bronchiectasis in China and identify the differences of bronchiectasis between the western countries and China; (2) identify the risk factors associated with disease progression in Chinese population; (3) elucidate the phenotype and endotype of bronchiectasis by integrating the genome, microbiome, proteome, and transcriptome with detailed clinical data; (4) facilitate large randomized controlled trials in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The BE-China is an ongoing prospective, longitudinal, multi-center, observational cohort study aiming to recruit a minimum of 10,000 patients, which was initiated in January 2020 in China. Comprehensive data, including medical history, aetiological testing, lung function, microbiological profiles, radiological scores, comorbidities, mental status, and quality of life (QoL), will be collected at baseline. Patients will be followed up annually for up to 10\u00a0years to record longitudinal data on outcomes, treatment patterns and QoL. Biospecimens, if possible, will be collected and stored at \u2212\u200980\u00a0\u00b0C for further research. Up to October 2021, the BE-China has enrolled 3758 patients, and collected 666 blood samples and 196 sputum samples from 91 medical centers. The study protocol has been approved by the Shanghai Pulmonary Hospital ethics committee, and all collaborating centers have received approvals from their local ethics committee. All patients will be required to provide written informed consent to their participation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings of the BE-China will be crucial to reveal the clinical characteristics and natural history of bronchiectasis and facilitate evidence-based clinical practice in China.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Registration Number in ClinicalTrials.gov: NCT03643653<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02254-9","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T18:02:18Z","timestamp":1670090538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study"],"prefix":"10.1186","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct03643653","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yong-Hua","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Qing","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"2254_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","volume":"4","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Prim. 2018;4:45.","journal-title":"Nat Rev Dis Prim"},{"key":"2254_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/13993003.01033-2015","volume":"47","author":"JK Quint","year":"2016","unstructured":"Quint JK, Millett ERC, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47:186\u201393.","journal-title":"Eur Respir J"},{"key":"2254_CR3","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1183\/13993003.00954-2015","volume":"46","author":"FC Ringshausen","year":"2015","unstructured":"Ringshausen FC, Roux AD, Diel R, et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46:1805\u20137.","journal-title":"Eur Respir J"},{"key":"2254_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12931-022-02023-8","volume":"23","author":"J Feng","year":"2022","unstructured":"Feng J, Sun L, Sun X, et al. Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013\u20132017: a nationwide population-based cohort study. Respir Res. 2022;23:111.","journal-title":"Respir Res"},{"key":"2254_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"2254_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","volume":"10","author":"S Aliberti","year":"2022","unstructured":"Aliberti S, Goeminne PC, O\u2019Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10:298\u2013306.","journal-title":"Lancet Respir Med"},{"key":"2254_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1378\/chest.13-1891","volume":"146","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, Marciel KK, Salathe MA, et al. A preliminary qualify of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis. Chest. 2014;146:437\u201348.","journal-title":"Chest"},{"key":"2254_CR8","doi-asserted-by":"publisher","first-page":"1601532","DOI":"10.1183\/13993003.01532-2016","volume":"49","author":"A Spinou","year":"2017","unstructured":"Spinou A, Siegert RJ, Guan WJ, et al. The development and validation of the bronchiectasis health questionnaire. Eur Respir J. 2017;49:1601532.","journal-title":"Eur Respir J"},{"key":"2254_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","volume":"43","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2014","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, de Gracia J, VendrellRelat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357\u201367.","journal-title":"Eur Respir J"},{"key":"2254_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, Gir\u00f3n R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275\u201384.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2254_CR11","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1111\/crj.12911","volume":"12","author":"H Wang","year":"2018","unstructured":"Wang H, Ji XB, Li CW, et al. Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis. Clin Respir J. 2018;12:2346\u201353.","journal-title":"Clin Respir J"},{"key":"2254_CR12","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"2254_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369.","journal-title":"Thorax"},{"key":"2254_CR14","first-page":"311","volume":"44","author":"Bronchiectasis Expert Consensus Writing Group","year":"2021","unstructured":"Bronchiectasis Expert Consensus Writing Group, Pulmonary Infection Assembly, Chinese Thoracic Society. Expert consensus on the diagnosis and treatment of adult bronchiectasis in China. Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:311\u201321.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2254_CR15","doi-asserted-by":"publisher","first-page":"1701926","DOI":"10.1183\/13993003.01926-2017","volume":"51","author":"G Mu\u00f1oz","year":"2018","unstructured":"Mu\u00f1oz G, de Gracia J, Bux\u00f3 M, et al. Long-term benefits of airway clearance in bronchiectasis: a randomized placebo-controlled trial. Eur Respir J. 2018;51:1701926.","journal-title":"Eur Respir J"},{"key":"2254_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","volume":"7","author":"JD Chalmers","year":"2019","unstructured":"Chalmers JD, Boersma W, Lonergan M, et al. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir Med. 2019;7:845\u201354.","journal-title":"Lancet Respir Med"},{"key":"2254_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","volume":"7","author":"IF Laska","year":"2019","unstructured":"Laska IF, Crichton ML, Shoemark A, et al. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir Med. 2019;7:855\u201369.","journal-title":"Lancet Respir Med"},{"key":"2254_CR18","doi-asserted-by":"publisher","first-page":"00081","DOI":"10.1183\/23120541.00081-2015","volume":"2","author":"JD Chalmers","year":"2016","unstructured":"Chalmers JD, Aliberti S, Polverino E, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ Open Res. 2016;2:00081.","journal-title":"ERJ Open Res"},{"key":"2254_CR19","doi-asserted-by":"publisher","first-page":"1802074","DOI":"10.1183\/13993003.02074-2018","volume":"52","author":"S Aliberti","year":"2018","unstructured":"Aliberti S, Polverino E, Chalmers JD, et al. The European multicentre bronchiectasis audit and research collaboration (EMBARC) ERS clinical research collaboration. Eur Respir J. 2018;52:1802074.","journal-title":"Eur Respir J"},{"key":"2254_CR20","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","volume":"7","author":"R Dhar","year":"2019","unstructured":"Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network India registry. Lancet Glob Health. 2019;7:e1269\u201379.","journal-title":"Lancet Glob Health"},{"key":"2254_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017;151:982\u201392.","journal-title":"Chest"},{"key":"2254_CR22","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","volume":"12","author":"S Lonni","year":"2015","unstructured":"Lonni S, Chalmers JD, Goeminne PC, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12:1764\u201370.","journal-title":"Ann Am Thorac Soc"},{"key":"2254_CR23","doi-asserted-by":"publisher","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","volume":"51","author":"D Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo D, Shteinberg M, Aliberti S, et al. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018;51:1701953.","journal-title":"Eur Respir J"},{"key":"2254_CR24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969\u201379.","journal-title":"Lancet Respir Med"},{"key":"2254_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1164\/rccm.201910-1972OC","volume":"201","author":"YH Gao","year":"2020","unstructured":"Gao YH, Abo Leyah H, Finch S, et al. Relationship between symptoms, exacerbations, and treatment response in bronchiectasis. Am J Respir Crit Care Med. 2020;201:1499\u2013507.","journal-title":"Am J Respir Crit Care Med"},{"key":"2254_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis. Am J Respir Crit Care Med. 2018;197:1410\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"2254_CR27","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.4103\/0366-6999.238134","volume":"131","author":"N Wang","year":"2018","unstructured":"Wang N, Qu JM, Xu JF. Bronchiectasis management in China, what we can learn from European respiratory society guidelines. Chin Med J. 2018;131:1891\u20133.","journal-title":"Chin Med J"},{"key":"2254_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1513\/AnnalsATS.201511-740PS","volume":"13","author":"JL Lin","year":"2016","unstructured":"Lin JL, Xu JF, Qu JM. Bronchiectasis in China. Ann Am Thorac Soc. 2016;13:609\u201316.","journal-title":"Ann Am Thorac Soc"},{"key":"2254_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034090","volume":"10","author":"H Lee","year":"2020","unstructured":"Lee H, Choi H, Sim YS, et al. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open. 2020;10: e034090.","journal-title":"BMJ Open"},{"key":"2254_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/resp.14059","volume":"26","author":"H Lee","year":"2021","unstructured":"Lee H, Choi H, Chalmers JD, et al. Characteristics of bronchiectasis in Korea: first data from the Korean multicenter bronchiectasis audit and research collaboration registry and comparison with other international registries. Respirology. 2021;26:619\u201321.","journal-title":"Respirology"},{"key":"2254_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.rmed.2019.07.016","volume":"155","author":"SK Visser","year":"2019","unstructured":"Visser SK, Bye PTP, Fox GJ, et al. Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry. Respir Med. 2019;155:97\u2013103.","journal-title":"Respir Med"},{"key":"2254_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12890-018-0638-0","volume":"18","author":"R Chandrasekaran","year":"2018","unstructured":"Chandrasekaran R, Mac Aog\u00e1in M, Chalmers JD, et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018;18:83.","journal-title":"BMC Pulm Med"},{"key":"2254_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1164\/rccm.201812-2351OC","volume":"200","author":"S Finch","year":"2019","unstructured":"Finch S, Shoemark A, Dicker AJ, et al. Pregnancy zone protein is associated with airway infection, neutrophil extracellular trap formation, and disease severity in bronchiectasis. Am J Respir Crit Care Med. 2019;200:992\u20131001.","journal-title":"Am J Respir Crit Care Med"},{"key":"2254_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","volume":"9","author":"HR Keir","year":"2021","unstructured":"Keir HR, Shoemark A, Dicker AJ, et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021;9:873\u201384.","journal-title":"Lancet Respir Med"},{"key":"2254_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","volume":"9","author":"AJ Dicker","year":"2021","unstructured":"Dicker AJ, Lonergan M, Keir HR, et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021;9:885\u201396.","journal-title":"Lancet Respir Med"},{"issue":"22","key":"2254_CR36","first-page":"01247","volume":"S0012\u20133692","author":"WJ Guan","year":"2022","unstructured":"Guan WJ, Xu JF, Luo H, et al. A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection. Chest. 2022;S0012\u20133692(22):01247\u20138.","journal-title":"Chest"},{"key":"2254_CR37","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/crj.12695","volume":"12","author":"YH Gao","year":"2018","unstructured":"Gao YH, Guan WJ, Zhu YN, et al. Anxiety and depression in adult outpatients with bronchiectasis: associations with disease severity and health-related quality of life. Clin Respir J. 2018;12:1485\u201394.","journal-title":"Clin Respir J"},{"key":"2254_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/resp.12528","volume":"20","author":"WJ Guan","year":"2015","unstructured":"Guan WJ, Gao YH, Xu G, et al. Aetiology of bronchiectasis in Guangzhou, southern China. Respirology. 2015;20:739\u201348.","journal-title":"Respirology"},{"key":"2254_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00160508","volume":"34","author":"MP Murray","year":"2009","unstructured":"Murray MP, Turnbull K, MacQuarrie S, et al. Validation of the Leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34:125\u201331.","journal-title":"Eur Respir J"},{"key":"2254_CR40","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.5588\/ijtld.14.0195","volume":"18","author":"YH Gao","year":"2014","unstructured":"Gao YH, Guan WJ, Xu G, et al. Validation of the Mandarin Chinese version of the Leicester cough questionnaire in bronchiectasis. Int J Tuberc Lung Dis. 2014;18:1431\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2254_CR41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1183\/13993003.01888-2015","volume":"48","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Masefield S, Polverino E, et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC clinical research collaboration. Eur Respir J. 2016;48:632\u201347.","journal-title":"Eur Respir J"},{"key":"2254_CR42","doi-asserted-by":"publisher","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","volume":"49","author":"AT Hill","year":"2017","unstructured":"Hill AT, Haworth CS, Aliberti S, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49:1700051.","journal-title":"Eur Respir J"},{"key":"2254_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1183\/09031936.00163208","volume":"34","author":"MP Murray","year":"2009","unstructured":"Murray MP, Pentland JL, Turnbull K, et al. Sputum color: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34:361\u20134.","journal-title":"Eur Respir J"},{"key":"2254_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"2254_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.chest.2017.11.033","volume":"153","author":"P Bedi","year":"2018","unstructured":"Bedi P, Chalmers JD, Goeminne PC, et al. The BRICS (bronchiectasis radiologically indexed CT score): a multicenter study score for use in idiopathic and postinfective bronchiectasis. Chest. 2018;153:1177\u201386.","journal-title":"Chest"},{"key":"2254_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1378\/chest.07-1639","volume":"133","author":"AH Alzeer","year":"2008","unstructured":"Alzeer AH, Al-Mobeirek AF, Al-Otair HA, et al. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest. 2008;133:468\u201373.","journal-title":"Chest"},{"key":"2254_CR47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s11684-016-0461-z","volume":"10","author":"L Wang","year":"2016","unstructured":"Wang L, Jiang S, Shi J, et al. Clinical characteristics of pulmonary hypertension in bronchiectasis. Front Med. 2016;10:336\u201344.","journal-title":"Front Med"},{"key":"2254_CR48","doi-asserted-by":"publisher","first-page":"00775","DOI":"10.1183\/23120541.00775-2020","volume":"7","author":"A De Soyza","year":"2021","unstructured":"De Soyza A, Mawson P, Hill AT, et al. BronchUK: protocol for an observational cohort study and biobank in bronchiectasis. ERJ Open Res. 2021;7:00775\u20132020.","journal-title":"ERJ Open Res"},{"key":"2254_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.arbres.2019.12.021","volume":"57","author":"MA Martinez-Garc\u00eda","year":"2021","unstructured":"Martinez-Garc\u00eda MA, Villa C, Dobarganes Y, et al. RIBRON: the Spanish online bronchiectasis registry. Characterization of the first 1912 patients. Arch Bronconeumol. 2021;57:28\u201335.","journal-title":"Arch Bronconeumol"},{"key":"2254_CR50","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","volume":"383","author":"JD Chalmers","year":"2020","unstructured":"Chalmers JD, Haworth CS, Metersky ML, et al. Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2020;383:2127\u201337.","journal-title":"N Engl J Med"},{"key":"2254_CR51","doi-asserted-by":"publisher","first-page":"1702052","DOI":"10.1183\/13993003.02052-2017","volume":"51","author":"A De Soyza","year":"2018","unstructured":"De Soyza A, Aksamit T, Bandel TJ, et al. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018;51:1702052.","journal-title":"Eur Respir J"},{"key":"2254_CR52","doi-asserted-by":"publisher","first-page":"1702053","DOI":"10.1183\/13993003.02053-2017","volume":"51","author":"T Aksamit","year":"2018","unstructured":"Aksamit T, De Soyza A, Bandel TJ, et al. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018;51:1702053.","journal-title":"Eur Respir J"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02254-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T06:03:54Z","timestamp":1670133834000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02254-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02254-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received necessary approval from institutional Review Boards of all participating institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}